This morning we received the news that the most significant medical imaging company is upgrading its EPR fleet to Trophon 2. It is doing so mainly for the compliance features of T2 over T1. accuracy of facility records and traceability of probe disinfection is now of paramount importance. There is a fleet of some 24000 Trophons out there. The majority are EPRs. They will now to upgraded with haste. COVID has made this inevitable and near at hand.
- Forums
- ASX - By Stock
- NAN
- NAN NOV 5 2020
NAN NOV 5 2020, page-25
-
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NAN (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.31 |
Change
0.160(5.08%) |
Mkt cap ! $1.002B |
Open | High | Low | Value | Volume |
$3.37 | $3.48 | $3.28 | $13.77M | 4.080M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 60232 | $3.30 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.32 | 2090 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 47420 | 3.300 |
2 | 2622 | 3.290 |
4 | 14390 | 3.280 |
3 | 4950 | 3.270 |
2 | 6102 | 3.260 |
Price($) | Vol. | No. |
---|---|---|
3.370 | 14694 | 2 |
3.380 | 9738 | 2 |
3.390 | 9840 | 2 |
3.400 | 1102 | 1 |
3.410 | 1102 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
NAN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online